Synthesis of deuterium-labelled peptido-aminobenzophenone [4-chloro-2-(2′-chlorobenzoyl)-N-(glycylglycyl)-N-methyl-anilide] and its metabolites
✍ Scribed by Shin'Ichirō Hashimoto; Shirō Takahashi
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- French
- Weight
- 529 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Deuterium‐labelled peptido‐aminobenzophenone [4‐chloro‐2‐(2′‐chlorobenzoyl)‐N‐(glycylglycl)‐N‐methylanilide, 1] and its benzodiazepine‐metabolites were prepared for use as internal standards in the quantification of the peptido‐aminobenzophenone, chlorodiazepam, lormetazepam, chlorodesmethyldiazepam, and lorazepam at low levels in human plasma by selected ion monitoring.
📜 SIMILAR VOLUMES
A high-performance liquid chromatographic method with spectrofluorometric detection has been developed for the analysis of a new substituted benzamide and its metabolite in body fluids. The detection was performed at 270 nm for excitation, and 370 nm for emission. The proposed technique is selective
## Abstract Carbon‐14 labeled Straterra^TM^ (Atomoxetine HCl, LY139603, (‐)‐__N__‐methyl‐3‐(2‐methylphenoxy)‐benzenepropanamine hydrochloride), a potent inhibitor of the presynaptic norepinephrine transporter, and two of its major metabolites were synthesized. The key component, __S__‐(+)‐3‐chloro‐
The compound 6-chloro-2,3,4,5-tetrahydroi~-methyl-l &3-t#nzazepine (SK&F 86466) was prepared in phenyl-U-C and phenyl-C , labeled forms in a six step sequence beginning with the appropriately labeled benzenes. In addition, the N-desmeJhyl analog of the carbon-1 4 labeled isotopomer and the N-methyl-
## Abstract A new potent neuroleptic agent YM‐09151‐2, N‐[(2RS, 3RS)‐1‐benzyl‐2‐methyl‐3‐pyrrolidinyl]‐5‐chloro‐2‐methoxy‐4‐ (methylamino) benzamide (**10c**), was labeled with carbon‐14 and deuterium for biochemical studies such as metabolism and 14 pharmacokinetics. The synthesis of [carbonyl‐^14